Jason Rhodes

Co-Founder at Disarm Therapeutics, Inc.

Jason Rhodes

Jason Rhodes

Co-Founder at Disarm Therapeutics, Inc.

Overview
Career Highlights

FORUM Pharmaceuticals, Inc.
Epizyme, Inc.
Dyne Therapeutics, Inc.

RelSci Relationships

4354

Number of Boards

14

Birthday

1969

Age

52
Contact Data
Trying to get in touch with Jason Rhodes? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Relationships
View Relationship Details
RelSci Relationships are individuals Jason Rhodes likely has professional access to. A relationship does not necessarily indicate a personal connection.
Bruce Booth

Co-Founder at Rodin Therapeutics, Inc.

Relationship likelihood: Strong

Geoff McDonough

President & Chief Executive Officer at Generation Bio Co.

Relationship likelihood: Strong

Ankit Mahadevia

Co-Founder at Translate Bio, Inc.

Relationship likelihood: Strong

David Grayzel

President, Treasurer & Director at Q32 Bio, Inc.

Relationship likelihood: Strong

Jeffrey D. Milbrandt

Co-Founder at Disarm Therapeutics, Inc.

Relationship likelihood: Strong

Robert Coffin

Co-Founder at Replimune Group, Inc.

Relationship likelihood: Strong

Robert Kotin

Founder at Generation Bio Co.

Relationship likelihood: Strong

Rajesh Devraj

Venture Partner at Atlas Venture, Inc.

Relationship likelihood: Strong

Joshua Brumm

President & Chief Executive Officer at Dyne Therapeutics, Inc.

Relationship likelihood: Strong

Peter Barrett

Executive Chairman at Synlogic, Inc.

Relationship likelihood: Strong

Reveal deeper insights into your organization's relationships
with RelSci Contact Aggregator.

Empower Your Business Applications with Industry-Leading
Relationship Data from the RelSci API.

Get Contact Information on the
World's Most Influential Decision Makers.

Discover the Power of Your Network with
RelSci Premium Products.
In The News
RelSci
February 21, 2021
Jason Rhodes is now serving in a new board position at Gemini Therapeutics, Inc.
GlobeNewswire
November 19, 2020
The Alliance for Regenerative Medicine Announces Record Sector Financing in 2020
Business Wire
November 16, 2020
Atlas Venture Welcomes Rajesh Devraj, PhD, as Venture Partner
Business Wire
October 22, 2020
Be Biopharma Launches with $52 Million Series A Financing to Advance B Cells as Medicines; -- Creating new category of cellular medicines --
FierceBiotech
June 5, 2020
Atlas banks $400M in its latest 'breakthrough biotech' fund
Trending People
Nigel Boardman
Greensill: Head of David Cameron lobbying inquiry 'opposed his curbs to lobbying... - The Independent UK
Lex Greensill
Greensill: Head of David Cameron lobbying inquiry 'opposed his curbs to lobbying... - The Independent UK
Tony Blinken
Japan approves plan to dump 1 million tonnes of waste water from Fukushima nucle... - Business Insider
Jennifer Rene Psaki
White House says U.S. wasn't involved in attack on Iranian nuclear facility - The Washington Times
Gretchen Whitmer
Workers weary, patients angry; COVID-19 fills hospitals in Michigan - again - USA Today
Trending People
Nigel Boardman
Greensill: Head of David Cameron lobbying inquiry 'opposed his curbs to lobbying... - The Independent UK
Lex Greensill
Greensill: Head of David Cameron lobbying inquiry 'opposed his curbs to lobbying... - The Independent UK
Tony Blinken
Japan approves plan to dump 1 million tonnes of waste water from Fukushima nucle... - Business Insider
Jennifer Rene Psaki
White House says U.S. wasn't involved in attack on Iranian nuclear facility - The Washington Times
Gretchen Whitmer
Workers weary, patients angry; COVID-19 fills hospitals in Michigan - again - USA Today
Paths to Jason Rhodes
Potential Connections via
Relationship Science
You
Jason Rhodes
Co-Founder at Disarm Therapeutics, Inc.
Education
MBA
Class of 1996
University of Pennsylvania - The Wharton School

The Wharton School is the business school of the University of Pennsylvania, an Ivy League university in Philadelphia, Pennsylvania. Wharton was the world’s first collegiate business school and the first business school in the United States. It was established in 1881 through a donation of Joseph Wharton.

BA Unknown
Class of 1991
Yale University

Yale University is an American private Ivy League research university located in New Haven, Connecticut. Founded in 1701 in the Colony of Connecticut, the university is the third-oldest institution of higher education in the United States.

Career History
Chairman
2017 - Current
Dyne Therapeutics, Inc.

Dyne Therapeutics, Inc. engages in developing innovative life-transforming therapies for genetically driven muscle diseases. It develops a broad portfolio of therapeutics for muscle diseases, including lead programs in myotonic dystrophy type 1, Duchenne muscular dystrophy, and facioscapulohumeral muscular dystroph. The company was founded by Jason P. Rhodes and Romesh R. Subramanian on December 1, 2017 and is headquartered in Waltham, MA.

Co-Founder
2016 - Current
Disarm Therapeutics, Inc.

Disarm Therapeutics, Inc. engages in the development of therapeutics to treat patients with neurological diseases. It includes multiple sclerosis, amyotrophic lateral sclerosis, glaucoma, and peripheral neuropathies. The company was founded by Jason Rhodes, Jeffrey Milbrandt, Raul Krauss, Aaron DiAntonio, and Rajesh Devraj on October 21, 2016 and is headquartered in Cambridge, MA.

Chairman
2016 - Current
Generation Bio Co.

Generation Bio Co. is a genetic medicines company focuses on creating a new class of gene therapy to provide durable and redosable treatment for patients suffering from both rare and prevalent diseases. Its non-viral platform incorporates a proprietary high-capacity DNA construct called closed-ended DNA, or ceDNA; a novel cell-targeted lipid nanoparticle delivery system, or ctLNP; and an established, scalable capsid-free manufacturing process. The company was founded by Mark D. Angelino, Jason P. Rhodes, and Robert M. Kotin in 2016 and is headquartered in Cambridge, MA.

Boards & Committees
Director
Prior
Mersana Therapeutics, Inc.

Mersana Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on developing antibody drug conjugates that offer clinical benefit for cancer patients with significant unmet need. Its product candidates are Upifitamab Rilsodotin (UpRi), XMT-1536, and XMT-1592. The company was founded by Mikhail Papisov in 2001 and is headquartered in Cambridge, MA.
Political Donations
$5
2018
ActBlue

ActBlue is an online toolset that makes it easy for donors to connect with the candidates and causes they support. At ActBlue, the objective is to democratize power by putting powerful fundraising tools in the hands of grassroots donors across the United States.

$25
2018
ActBlue

ActBlue is an online toolset that makes it easy for donors to connect with the candidates and causes they support. At ActBlue, the objective is to democratize power by putting powerful fundraising tools in the hands of grassroots donors across the United States.

$50
2018
ActBlue

ActBlue is an online toolset that makes it easy for donors to connect with the candidates and causes they support. At ActBlue, the objective is to democratize power by putting powerful fundraising tools in the hands of grassroots donors across the United States.

Transactions
Details Hidden

Epizyme, Inc. issued USD Common Stock

Investments
Details Hidden
Dyne Therapeutics, Inc.

Dyne Therapeutics, Inc. engages in developing innovative life-transforming therapies for genetically driven muscle diseases. It develops a broad portfolio of therapeutics for muscle diseases, including lead programs in myotonic dystrophy type 1, Duchenne muscular dystrophy, and facioscapulohumeral muscular dystroph. The company was founded by Jason P. Rhodes and Romesh R. Subramanian on December 1, 2017 and is headquartered in Waltham, MA.

Details Hidden
Generation Bio Co.

Generation Bio Co. is a genetic medicines company focuses on creating a new class of gene therapy to provide durable and redosable treatment for patients suffering from both rare and prevalent diseases. Its non-viral platform incorporates a proprietary high-capacity DNA construct called closed-ended DNA, or ceDNA; a novel cell-targeted lipid nanoparticle delivery system, or ctLNP; and an established, scalable capsid-free manufacturing process. The company was founded by Mark D. Angelino, Jason P. Rhodes, and Robert M. Kotin in 2016 and is headquartered in Cambridge, MA.

Details Hidden
Disarm Therapeutics, Inc.

Disarm Therapeutics, Inc. engages in the development of therapeutics to treat patients with neurological diseases. It includes multiple sclerosis, amyotrophic lateral sclerosis, glaucoma, and peripheral neuropathies. The company was founded by Jason Rhodes, Jeffrey Milbrandt, Raul Krauss, Aaron DiAntonio, and Rajesh Devraj on October 21, 2016 and is headquartered in Cambridge, MA.

Other Affiliations

Jason Rhodes is affiliated with Dyne Therapeutics, Inc., Disarm Therapeutics, Inc., Generation Bio Co., Atlas Venture, Inc., MPM Capital, Inc., Epizyme, Inc., F-Prime Capital Partners, Raze Therapeutics, Inc., FORUM Pharmaceuticals, Inc., FMR LLC, Alnylam Pharmaceuticals, Inc., Bicycle Therapeutics Plc, SlopeViews, Mersana Therapeutics, Inc.

Stay informed and up-to-date on your network with RelSci news and business alerting service. Nurture your network and further your business goals with smart intelligence on the people and companies that matter most to you.

Browse in-depth profiles on 12 million influential people and organizations. Find RelSci relationships, employment history, board memberships, donations, awards, and more.

Explore notable alumni from top universities and organizations. Expand your fundraising pool and make warm introductions to potential new business connections.

Harness the power of your relationships with RelSci Pro, the powerful platform for identifying relationship-driven business opportunities and connections that can propel your career forward.

Stay informed and up-to-date on your network with RelSci news and business alerting service. Nurture your network and further your business goals with smart intelligence on the people and companies that matter most to you.

Browse in-depth profiles on 12 million influential people and organizations. Find RelSci relationships, employment history, board memberships, donations, awards, and more.

Explore notable alumni from top universities and organizations. Expand your fundraising pool and make warm introductions to potential new business connections.

Harness the power of your relationships with RelSci Pro, the powerful platform for identifying relationship-driven business opportunities and connections that can propel your career forward.
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Jason Rhodes. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Jason Rhodes's profile does not indicate a business or promotional relationship of any kind between RelSci and Jason Rhodes.